CN103255174A - 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 - Google Patents
以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 Download PDFInfo
- Publication number
- CN103255174A CN103255174A CN2013101579801A CN201310157980A CN103255174A CN 103255174 A CN103255174 A CN 103255174A CN 2013101579801 A CN2013101579801 A CN 2013101579801A CN 201310157980 A CN201310157980 A CN 201310157980A CN 103255174 A CN103255174 A CN 103255174A
- Authority
- CN
- China
- Prior art keywords
- ternary complex
- liquid
- polyoxyethylene glycol
- hyaluronic acid
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 57
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 33
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 31
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 31
- 229920001223 polyethylene glycol Polymers 0.000 title abstract description 6
- 239000002202 Polyethylene glycol Substances 0.000 title abstract description 4
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 31
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 31
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 31
- 239000007864 aqueous solution Substances 0.000 claims abstract description 26
- 239000002245 particle Substances 0.000 claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 16
- 229920000578 graft copolymer Polymers 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 238000001415 gene therapy Methods 0.000 claims abstract description 9
- 238000003745 diagnosis Methods 0.000 claims abstract description 7
- 239000006185 dispersion Substances 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 111
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 74
- -1 polyoxyethylene Polymers 0.000 claims description 54
- 239000002105 nanoparticle Substances 0.000 claims description 48
- 238000002360 preparation method Methods 0.000 claims description 48
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 40
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 37
- 229920006317 cationic polymer Polymers 0.000 claims description 31
- 230000008685 targeting Effects 0.000 claims description 30
- 239000000178 monomer Substances 0.000 claims description 24
- BDLFEAFWNOROAK-UHFFFAOYSA-N 2,3-bis(hydroxymethyl)-4-methylphenol Chemical compound CC1=CC=C(O)C(CO)=C1CO BDLFEAFWNOROAK-UHFFFAOYSA-N 0.000 claims description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 11
- 239000010931 gold Substances 0.000 claims description 11
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 11
- 229920000728 polyester Polymers 0.000 claims description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 11
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 11
- 125000001246 bromo group Chemical group Br* 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 10
- 229910052737 gold Inorganic materials 0.000 claims description 10
- 150000002500 ions Chemical class 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 238000006116 polymerization reaction Methods 0.000 claims description 10
- 229920002554 vinyl polymer Polymers 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- VLCAYQIMSMPEBW-UHFFFAOYSA-N methyl 3-hydroxy-2-methylidenebutanoate Chemical compound COC(=O)C(=C)C(C)O VLCAYQIMSMPEBW-UHFFFAOYSA-N 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 150000002596 lactones Chemical class 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 230000003044 adaptive effect Effects 0.000 claims description 5
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 4
- 125000004423 acyloxy group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical group COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 2
- 238000001890 transfection Methods 0.000 abstract description 19
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 abstract 3
- 230000006806 disease prevention Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 33
- 238000000034 method Methods 0.000 description 33
- 229920002246 poly[2-(dimethylamino)ethyl methacrylate] polymer Polymers 0.000 description 24
- 239000000243 solution Substances 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 15
- 125000004433 nitrogen atom Chemical group N* 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 108020004459 Small interfering RNA Proteins 0.000 description 11
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 229910002091 carbon monoxide Inorganic materials 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 108091023037 Aptamer Proteins 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 108010020346 Polyglutamic Acid Proteins 0.000 description 6
- 229920003118 cationic copolymer Polymers 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000031700 light absorption Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 229920002643 polyglutamic acid Polymers 0.000 description 6
- 229920005604 random copolymer Polymers 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920001610 polycaprolactone Polymers 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- OPCHFPHZPIURNA-MFERNQICSA-N (2s)-2,5-bis(3-aminopropylamino)-n-[2-(dioctadecylamino)acetyl]pentanamide Chemical compound CCCCCCCCCCCCCCCCCCN(CC(=O)NC(=O)[C@H](CCCNCCCN)NCCCN)CCCCCCCCCCCCCCCCCC OPCHFPHZPIURNA-MFERNQICSA-N 0.000 description 4
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 230000009881 electrostatic interaction Effects 0.000 description 4
- 230000030279 gene silencing Effects 0.000 description 4
- 238000012226 gene silencing method Methods 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000004632 polycaprolactone Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001476 gene delivery Methods 0.000 description 3
- 125000003827 glycol group Chemical group 0.000 description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 description 2
- 101710141544 Allatotropin-related peptide Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 229920001212 Poly(beta amino esters) Polymers 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 125000003929 folic acid group Chemical group 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 0 *C(C(O*N)=O)=* Chemical compound *C(C(O*N)=O)=* 0.000 description 1
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000012124 Opti-MEM Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920006022 Poly(L-lactide-co-glycolide)-b-poly(ethylene glycol) Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000005543 nano-size silicon particle Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000006807 siRNA silencing Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310157980.1A CN103255174B (zh) | 2013-05-02 | 2013-05-02 | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310157980.1A CN103255174B (zh) | 2013-05-02 | 2013-05-02 | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103255174A true CN103255174A (zh) | 2013-08-21 |
CN103255174B CN103255174B (zh) | 2015-10-28 |
Family
ID=48959383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310157980.1A Active CN103255174B (zh) | 2013-05-02 | 2013-05-02 | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103255174B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104931684A (zh) * | 2015-02-28 | 2015-09-23 | 青岛科技大学 | 一种纳米荧光传感器及其制备方法和应用 |
CN105823775A (zh) * | 2016-03-22 | 2016-08-03 | 中国石油大学(华东) | 硫代磷酸酯类有机磷农药残留检测试剂盒及其应用方法 |
CN107142281A (zh) * | 2017-06-07 | 2017-09-08 | 东华大学 | 聚酰胺‑胺树状大分子与纳米金颗粒的复合物作为非病毒载体进行基因转染的应用方法 |
CN107216445A (zh) * | 2017-05-03 | 2017-09-29 | 南京大学 | 一种纳米复合物及其制备方法与应用 |
CN108524946A (zh) * | 2018-04-04 | 2018-09-14 | 苏州大学 | 三元复合物纳米药物及其制备方法以及在制备光可控释放纳米递送体系中的应用 |
CN109550057A (zh) * | 2018-12-05 | 2019-04-02 | 四川大学 | 主动靶向型基因递送纳米粒及其制备方法和应用 |
CN111195238A (zh) * | 2018-10-31 | 2020-05-26 | 南方医科大学 | 一种用于胰岛素口服递送的聚电解质复合物 |
CN115336760A (zh) * | 2022-08-16 | 2022-11-15 | 河南科技学院 | 一种基于交叉水凝胶构建的超稳定混合型高内相乳液体系及其制备方法 |
CN115429774A (zh) * | 2022-08-30 | 2022-12-06 | 重庆医科大学 | 一种仿生膜包裹尿酸酶纳米粒及其制备方法 |
WO2022262050A1 (zh) * | 2021-06-17 | 2022-12-22 | 苏州大学 | 一种非病毒载体及其制备方法与应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018434176A1 (en) * | 2018-07-27 | 2021-01-28 | Zentrum Für Forschungsförderung In Der Pädiatrie Gmbh | Improved concepts for the treatment of genetic disorders with high-capacity plal-generated gold nanoparticles |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684174A (zh) * | 2008-07-09 | 2010-03-31 | 天津大学 | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 |
CN101864065A (zh) * | 2010-06-13 | 2010-10-20 | 天津大学 | 含环醚侧基的可生物降解两亲性嵌段共聚物及其制备方法和应用 |
CN102477439A (zh) * | 2010-11-22 | 2012-05-30 | 苏州瑞博生物技术有限公司 | 三元复合物和含有三元复合物的液体及制备方法与应用 |
-
2013
- 2013-05-02 CN CN201310157980.1A patent/CN103255174B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684174A (zh) * | 2008-07-09 | 2010-03-31 | 天津大学 | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 |
CN101864065A (zh) * | 2010-06-13 | 2010-10-20 | 天津大学 | 含环醚侧基的可生物降解两亲性嵌段共聚物及其制备方法和应用 |
CN102477439A (zh) * | 2010-11-22 | 2012-05-30 | 苏州瑞博生物技术有限公司 | 三元复合物和含有三元复合物的液体及制备方法与应用 |
Non-Patent Citations (2)
Title |
---|
董岸杰等: "Amphiphilic Methoxy Poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2-dimethylaminoethyl methacrylate) Cationic Copolymer Nanoparticles as a Vector for Gene and Drug Delivery", 《BIOMACROMOLECULES》, vol. 11, no. 9, 28 July 2010 (2010-07-28), pages 2306 - 2312 * |
董岸杰等: "The use of PEGylatedpoly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses", 《BIOMATERIALS》, vol. 31, no. 1, 24 September 2009 (2009-09-24), pages 1 - 10 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104931684A (zh) * | 2015-02-28 | 2015-09-23 | 青岛科技大学 | 一种纳米荧光传感器及其制备方法和应用 |
CN105823775A (zh) * | 2016-03-22 | 2016-08-03 | 中国石油大学(华东) | 硫代磷酸酯类有机磷农药残留检测试剂盒及其应用方法 |
CN105823775B (zh) * | 2016-03-22 | 2017-06-30 | 中国石油大学(华东) | 硫代磷酸酯类有机磷农药残留检测试剂盒及其应用方法 |
CN107216445B (zh) * | 2017-05-03 | 2020-02-21 | 南京大学 | 一种纳米复合物及其制备方法与应用 |
CN107216445A (zh) * | 2017-05-03 | 2017-09-29 | 南京大学 | 一种纳米复合物及其制备方法与应用 |
CN107142281A (zh) * | 2017-06-07 | 2017-09-08 | 东华大学 | 聚酰胺‑胺树状大分子与纳米金颗粒的复合物作为非病毒载体进行基因转染的应用方法 |
CN108524946B (zh) * | 2018-04-04 | 2020-09-25 | 苏州大学 | 三元复合物纳米药物及其制备方法以及在制备光可控释放纳米递送体系中的应用 |
CN108524946A (zh) * | 2018-04-04 | 2018-09-14 | 苏州大学 | 三元复合物纳米药物及其制备方法以及在制备光可控释放纳米递送体系中的应用 |
CN111195238A (zh) * | 2018-10-31 | 2020-05-26 | 南方医科大学 | 一种用于胰岛素口服递送的聚电解质复合物 |
CN109550057A (zh) * | 2018-12-05 | 2019-04-02 | 四川大学 | 主动靶向型基因递送纳米粒及其制备方法和应用 |
WO2022262050A1 (zh) * | 2021-06-17 | 2022-12-22 | 苏州大学 | 一种非病毒载体及其制备方法与应用 |
CN115336760A (zh) * | 2022-08-16 | 2022-11-15 | 河南科技学院 | 一种基于交叉水凝胶构建的超稳定混合型高内相乳液体系及其制备方法 |
CN115336760B (zh) * | 2022-08-16 | 2024-04-30 | 河南科技学院 | 一种基于交叉水凝胶构建的超稳定混合型高内相乳液体系及其制备方法 |
CN115429774A (zh) * | 2022-08-30 | 2022-12-06 | 重庆医科大学 | 一种仿生膜包裹尿酸酶纳米粒及其制备方法 |
CN115429774B (zh) * | 2022-08-30 | 2023-07-14 | 重庆医科大学 | 一种仿生膜包裹尿酸酶纳米粒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103255174B (zh) | 2015-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103255174B (zh) | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 | |
Pandey et al. | Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery | |
Rojanarata et al. | Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery | |
Wang et al. | Photoluminescent and biodegradable polycitrate-polyethylene glycol-polyethyleneimine polymers as highly biocompatible and efficient vectors for bioimaging-guided siRNA and miRNA delivery | |
US8716399B2 (en) | Polysaccharide-grafted polyethylenimine as a gene carrier | |
Qiu et al. | Dendrimer-entrapped gold nanoparticles modified with β-cyclodextrin for enhanced gene delivery applications | |
Zhou et al. | PLL/pDNA/P (His-co-DMAEL) ternary complexes: assembly, stability and gene delivery | |
WO2014066912A1 (en) | Polymeric nanoparticles | |
Mathew et al. | Hyperbranched PEGmethacrylate linear pDMAEMA block copolymer as an efficient non-viral gene delivery vector | |
Hou et al. | Partially acetylated dendrimer-entrapped gold nanoparticles with reduced cytotoxicity for gene delivery applications | |
Taratula et al. | Poly (propyleneimine) dendrimers as potential siRNA delivery nanocarrier: from structure to function | |
US20080160096A1 (en) | Polymeric nanoparticles by ion-ion interactions | |
US20230233693A1 (en) | Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery | |
US10640592B2 (en) | Cation polymer capable of removing positive charges through oxidative response, a preparation method and application | |
CN103110954A (zh) | 胆固醇修饰的生物可降解聚阳离子载体及制备方法和用途 | |
Fakhoury et al. | Antisense precision polymer micelles require less poly (ethylenimine) for efficient gene knockdown | |
WO2009138472A1 (en) | Amphiphilic block copolymers for nucleic acid delivery | |
Inada et al. | A silencing-mediated enhancement of osteogenic differentiation by supramolecular ternary siRNA polyplexes comprising biocleavable cationic polyrotaxanes and anionic fusogenic peptides | |
CN102250348B (zh) | 一种聚乙烯亚胺衍生物及其作为基因传递的载体 | |
Bansal et al. | Biodegradable and versatile polyethylenimine derivatives efficiently transfer DNA and siRNA into mammalian cells | |
CN102477439B (zh) | 三元复合物和含有三元复合物的液体及制备方法与应用 | |
Park et al. | Poly (L-lactic acid)/polyethylenimine nanoparticles as plasmid DNA carriers | |
KR100980395B1 (ko) | 비-바이러스성 유전자 전달체용 중합체/유전자 복합체 | |
Qi et al. | Contribution of cholesterol moieties attached on MPEG-b-PCL-b-PLL to the cell uptake, endosomal escape and gene knockdown of the micelleplexes of siRNA | |
JP2017515839A (ja) | 合成脳浸透遺伝子ベクターの操作 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210908 Address after: Room 109, no.1866, Bohai 12th Road, Port Economic Zone, Binhai New Area, Tianjin 300452 Patentee after: Tianjin Bohua Xinchuang Technology Co.,Ltd. Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92, Tianjin University Patentee before: Tianjin University |
|
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130821 Assignee: TIANJIN TIAN YUAN ELECTRICAL MATERIALS CO.,LTD. Assignor: Tianjin Bohua Xinchuang Technology Co.,Ltd. Contract record no.: X2024980003329 Denomination of invention: Liquid and application of ternary composites with polyethylene glycol grafted hyaluronic acid as outer layer and ternary composites Granted publication date: 20151028 License type: Common License Record date: 20240322 |